Summary & Overview
HCPCS G9510: Adult Depression 12-Month Non-Remission Assessment
HCPCS Level II code G9510 documents adult patients (18+) with major depression or dysthymia who have not reached remission after 12 months, based on PHQ-9 or PHQ-9M assessment within a ±60-day window. The code captures both documented non-remission (score ≥5) and instances where the relevant assessment was not performed. Nationally, this code supports tracking long-term treatment outcomes for depressive disorders and informs quality measurement, care management, and payment policies tied to behavioral health outcomes.
Key payers covered in typical analyses include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will learn the clinical context for using G9510, the expected service setting (outpatient behavioral health or primary care), and how the code fits into longitudinal depression care pathways. The report outlines benchmarking opportunities, relevant policy interpretation for payers, and operational implications for documentation and coding workflows. Data not available in the input will be noted where applicable.
Billing Code Overview
HCPCS Level II code G9510 identifies adult patients aged 18 and older with major depression or dysthymia who have not achieved remission at twelve months, as demonstrated by a twelve month (+/-60 days) PHQ-9 or PHQ-9M score of less than 5. The description also captures situations where either the PHQ-9 or PHQ-9M score was not assessed or is greater than or equal to 5.
-
Service type: Measurement and follow-up assessment for depression treatment response at the 12-month mark
-
Typical site of service: Outpatient behavioral health or primary care settings where depression screening and longitudinal follow-up occur
Clinical & Coding Specifications
Clinical Context
A 34-year-old adult patient with a documented history of major depressive disorder presents for a twelve-month outcome assessment after initiation of an evidence-based treatment plan. The clinician reviews longitudinal treatment records, medication adherence, psychotherapy visit frequency, and longitudinal PHQ-9 or PHQ-9M screening data. At the 12-month (+/- 60 days) interval the PHQ-9/PHQ-9M score was either not assessed or is greater than or equal to 5, indicating the patient has not reached remission (remission defined as PHQ-9 < 5). The workflow includes identification of patients due for the 12-month measurement, administration or documentation of the PHQ-9/PHQ-9M, EHR capture of the score, confirmation of diagnosis (for example, F33.1 Major depressive disorder, recurrent, moderate), care team communication, and billing for the quality measure/activity represented by G9510. Typical sites of service are outpatient behavioral health clinics, primary care offices, integrated behavioral health settings, and telehealth visits where measurement-based care is documented. The typical patient scenario involves ongoing pharmacotherapy and/or psychotherapy without symptom remission at one year, prompting care-team review of treatment adequacy, adherence, and potential adjustments in therapy while documenting the required 12-month measurement or lack thereof for reporting purposes.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |